Wednesday, Apr 10, 2024 · SEC filings

What the smart money revealed on Apr 10

Real insider buys26insiders · $2.77M
Real insider sales38insiders · $30.4M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

277 insider filings came in. We hid 41 planned (10b5-1) sellers and 158 people whose filings were routine, like grants and tax withholding.

trending_up

Seritage Growth Properties (SRG-PA) Director Russell Douglas bought $1.42M

60,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 8
$1.42M
trending_up

Neogen (NEOG) CEO John Adent bought $284K

23,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 3 beat Traded Apr 10
$284K
trending_up

Nexpoint Diversified Real Estate Trust (NXDT) Director Arthur Laffer bought $246K

40,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 5 beat Traded Apr 8–9
$246K
trending_up

Americas Carmart (CRMT) President and CEO Douglas Campbell Jr. bought $199K

3,229 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 8
$199K
trending_down

Riley Exploration Permian (REPX) Director Bryan Lawrence sold $17.9M

Not marked as a planned 10b5-1 sale. Sold 22% of the shares they held directly. Still holds 2.54M shares.

Real sale Form 4 Traded Apr 8
$17.9M
trending_down

Napco Security Technologies (NSSC) Pres Richard Soloway sold $2.04M

Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 1.66M shares.

Real sale Form 4 Traded Apr 8
$2.04M
trending_down

DocuSign (DOCU) Director Peter Solvik sold $900K

Not marked as a planned 10b5-1 sale. Sold 95% of the shares they held directly. Still holds 783 shares.

Real sale Form 4 Sold 95% of stake Traded Apr 9
$900K
Show 22 more real buys
NEOG Neogen · CFO David Naemura · Traded Apr 10
$156K
HCI HCI Group · CEO Paresh Patel · Traded Apr 9
$115K
WDI Western Asset Diversified Income Fund · Director Nisha Kumar · Traded Apr 8
$90K
GAM General American Investors · VP Administration/CCO/PFO Eugene Stark · Traded Apr 10
$62.5K
ANIX Anixa Biosciences · Director Lewis Titterton Jr. · Traded Apr 9
$49.2K
TRDA Entrada Therapeutics · Director Peter Kim · Traded Apr 8
$35.3K
ONCT Oncternal Therapeutics · Director Robert Wills · Traded Apr 8
$27.7K
DOMH Dominari · President Kyle Wool · Traded Apr 8
$25.4K
ANNX Annexon · Director William Carson · Traded Apr 8
$19.4K
BRTX BioRestorative Therapies · VP of Research and Development Francisco Silva · Traded Apr 8–9
$10.2K
TPL Texas Pacific Land · Director Murray Stahl · Traded Apr 9
$7.07K
RKT Rocket Companies · Director Matthew Rizik · Traded Apr 9–10
$5.75K
MMLP Martin Midstream Partners · President and CEO Robert Bondurant · Traded Apr 9
$4.25K
MMLP Martin Midstream Partners · Director Ruben Martin · Traded Apr 9
$2.18K
AUBN Auburn National Bancorporation · Director J. Tutt Barrett · Traded Apr 9
$1.79K
BSBK Bogota Financial · Executive Vice President Robert Walsh · Traded Apr 9
$1.71K
AUBN Auburn National Bancorporation · Director William Ham Jr. · Traded Apr 9
$1.38K
AUBN Auburn National Bancorporation · Director David Housel · Traded Apr 9
$1.23K
MMLP Martin Midstream Partners · Executive Vice President / CFO Sharon Taylor · Traded Apr 9
$1.05K
AUBN Auburn National Bancorporation · Senior Vice President Shannon O'donnell · Traded Apr 9
$656
MMLP Martin Midstream Partners · Senior VP Operations Scot Shoup · Traded Apr 9
$467
RCG RENN Fund · President and CEO Murray Stahl · Traded Apr 9
$92
Show 35 more real sales
FUL Fuller H B · Executive Vice President James East · Traded Apr 8
$1.75M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Apr 9
$1.68M
JBL Jabil · SVP May Yap · Traded Apr 8
$1.1M
FUL Fuller H B · Sr. VP Nathan Weaver · Traded Apr 9
$573K
JBL Jabil · EVP Gerald Creadon · Traded Apr 3
$407K
CPRX Catalyst Pharmaceuticals · Director David Tierney · Traded Apr 8
$392K
NCNO nCino · CEO Pierre Naude · Traded Apr 8
$376K
RCKT Rocket Pharmaceuticals · Officer Mark White · Traded Apr 8
$309K
PHR Phreesia · CEO Chaim Indig · Traded Apr 8
$272K
RUN Sunrun · CEO Mary Powell · Traded Apr 8
$272K
NAPA Duckhorn Portfolio · Officer Sean Sullivan · Traded Apr 9
$225K
RUN Sunrun · CFO Danny Abajian · Traded Apr 8
$211K
RUN Sunrun · Chief Revenue Officer Paul Dickson · Traded Apr 8
$180K
PHR Phreesia · CFO Balaji Gandhi · Traded Apr 8
$176K
PHR Phreesia · COO Evan Roberts · Traded Apr 8
$162K
REX Rex American Resources · Executive COB Stuart Rose · Traded Apr 9
$153K
IMVT Immunovant · CEO Peter Salzmann · Traded Apr 9
$150K
DBI Designer Brands · EVP Jared Poff · Traded Apr 8
$146K
RUN Sunrun · Chief Legal and People Officer Jeanna Steele · Traded Apr 8
$123K
HFBL Home Federal Bancorp, Inc. of Louisiana · Director Timothy Wilhite · Traded Apr 9
$122K
IMVT Immunovant · CFO Eva Barnett · Traded Apr 9
$115K
JBL Jabil · SVP Gary Schick · Traded Apr 9
$109K
PHR Phreesia · Principal Accounting Officer Janet Gunzburg · Traded Mar 19–Apr 8 · Filed late
$104K
PHR Phreesia · SVP David Linetsky · Traded Apr 8
$94.1K
NCNO nCino · CFO and Treasurer Gregory Orenstein · Traded Apr 8
$82.9K
NCNO nCino · Chief Customer Success Officer Sean Desmond · Traded Apr 8
$81.3K
NCNO nCino · President and Chief Rev Officer Joshua Glover · Traded Apr 8
$64.6K
PHAT Phathom Pharmaceuticals · CFO and CBO Molly Henderson · Traded Apr 8
$38.1K
IMVT Immunovant · Chief Development Officer Julia Butchko · Traded Apr 9
$32.8K
MXC Mexco Energy · President Tammy McComic · Traded Apr 8–9
$26.5K
MXC Mexco Energy · Secretary Stacy Hardin · Traded Apr 8–9
$16.7K
AXDX Accelerate Diagnostics · CTO Larry Mertz · Traded Apr 9
$12.2K
AXDX Accelerate Diagnostics · CFO David Patience · Traded Apr 9
$11.6K
RMNI Rimini Street · EVP and CFO Michael Perica · Traded Apr 8
$10K
GME GameStop · PFO and PAO Daniel Moore · Traded Apr 8
$5.92K

13F season

Holdings as of Mar 31, 2024 are due May 15

50 funds have filed so far. 49 filed for the quarter before.

Biggest real insider buys, Apr 4–10

Open-market buys by officers and directors, filed in the 7 days up to Apr 10.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist